Drug susceptibility in emerging fungal infections: tests with fluconazole, itraconazole, and amphotericin B
An. bras. dermatol
;
93(3): 462-464, May-June 2018. tab
Article
in English
| LILACS
| ID: biblio-1038269
ABSTRACT
Abstract The number of new cases of emerging fungal infections has increased considerably in recent years, mainly due to the large number of immunocompromised individuals. The objective of this study was to evaluate the susceptibility of emerging fungi to fluconazole, itraconazole and amphotericin B by disk diffusion method. In 2015, 82 emerging fungi were evaluated in IPB-LACEN/RS and 13 (15.8%) were resistant 10/52 were from superficial mycoses and 3/30 from systemic mycoses. The data from the study point to the need for permanent vigilance regarding the careful evaluation in the prescription and clinical and laboratory follow-up of patients affected by fungal infections.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Drug Resistance, Fungal
/
Fungi
/
Antifungal Agents
Type of study:
Incidence study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
Language:
English
Journal:
An. bras. dermatol
Journal subject:
Dermatology
Year:
2018
Type:
Article
Affiliation country:
Brazil
Institution/Affiliation country:
Secretaria de Saúde do Estado do Rio Grande do Sul/BR
/
Universidade Federal de Ciências da Saúde de Porto Alegre/BR
Similar
MEDLINE
...
LILACS
LIS